• Email Us: [email protected]
  • Contact Us: +1 718 874 1545
  • Skip to main content
  • Skip to primary sidebar

Medical Market Report

  • Home
  • All Reports
  • About Us
  • Contact Us

Five Seasons Ventures pulls in €180M fund to tackle human health and climate via FoodTech

October 4, 2021 by David Barret Leave a Comment

FoodTech is booming in Europe has grown exponentially. In 2020, €3 billion went into European FoodTech companies (State of European Tech Report, March 2021), and the pandemic has accelerated demand as consumers have shifted to grocery delivery. The industry has also been affected by the rise of direct-to-consumer food brands. Finally, the pandemic created a boom in interest in healthy food and nutrition to improve people’s immunity to COVID-19.

So it’s perhaps understandable that European FoodTech VC Five Seasons Ventures has announced the final closing of €180 million second fund. Their first fund was €77 million, so this next fund is a sizeable improvement and reflects what’s going on in Food Tech.

The new Fund II will continue making Series A and B investments into European FoodTech companies, with, says the company “an emphasis on fast-growing consumer-focused food with a quantifiable environmental or social impact.”

Five Seasons says it’s aiming to prove that FoodTech startups can grow as fast as ‘normal’ tech startups, with its Fund I portfolio on track to reach a combined revenue of over €350M in 2021, it says. One such company, Air Up, has hit a €100M revenue run rate in less than two years, says Five Seasons. Air-Up sells a reusable smart water bottle that “delivers flavor via retro-nasal scent”.

Ivan Farneti, Co-founding Partner of Five Seasons Ventures, said: “There’s no doubt that FoodTech is experiencing a boom in Europe right now. When we launched Five Seasons in 2018, we were the first VC to focus on FoodTech in Europe, and we believe we contributed to making this an attractive asset class. Fund II was quickly oversubscribed as more investors wanted to get exposed to European FoodTech, seeking high growth and impact.”

Five seasons has also backed Butternut Box, a direct-to-consumer fresh dog food company in Europe, and ‘This’, plant-based meat alternative. The VC’s team has also grown to nine, with the appointment of a Head of Impact and Sustainable Investing.

Fund II has so far invested in female wellness supplements her1, and vly, a company using peas to provide a plant-based milk alternative filled with protein. It’s also invested in Barkyn and The Nu Company. 

In total, Five Seasons Ventures has backed 14 companies across six European countries: Germany, France, Italy, Portugal, Switzerland, and the UK. 

In an interview, Niccolo Manzoni, Co-founding Partner of Five Seasons Ventures, added: “If you look at the amount of capital that has gone into FoodTech ventures in the last two years it’s grown from €1 billion to €3 billion just in Europe, and it’s bound to continue growing because there are lots of companies that have raised good money and have grown really fast.”

“Secondly, it also has the Impact side,” he said. “Two of the most pressing issues the world is facing today are human health and climate change. And that’s exactly the kind of companies we look for. If you look across our portfolio, for example, last year we saved about 2 million kilograms of food waste. The products that our companies sell are designed to improve health and well being… There’s a huge amount of things you can do in food tech which you cannot do in SaaS, for example.”

Source Link Five Seasons Ventures pulls in €180M fund to tackle human health and climate via FoodTech

David Barret
David Barret

Related posts:

  1. Special Report-How the Chinese tycoon driving Volvo plans to tackle Tesla
  2. Taiwan lands fighters on highway as annual drills reach peak
  3. Euro zone production stronger than expected in July
  4. Aurora Cannabis targets more cost cuts on path to profitability

Filed Under: News

Reader Interactions

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Primary Sidebar

  • IFLScience The Big Questions: Why Do People Believe In The Paranormal?
  • What Is “Japanese Walking”, And Should You Be Doing It?
  • AI Chatbots Found To Violate Ethical Standards When It Comes To Mental Health Discussions
  • Finding The Last Saolas: The Hunt For One Of The World’s Rarest Mammals Is On
  • This Is What People Actually See When They Have A Near-Death Experience
  • Bird Flu Is Making Headlines Once Again: What’s The Current Situation?
  • A Whale Protected A Scientist From A Huge Shark. A Year And 15 Days Later, They Were Reunited
  • This 600-Year-Old Inca Building Was Designed For An Incredible Acoustic Reason
  • Up To 90 Percent Of People Have This Health Condition. Just As Many Have Never Heard Of It
  • A Forgotten 19th Century “Vortex” Model Of The Atom May Help Explain Why The Universe Exists At All
  • Potential Environmental Trigger For Autism Identified, But Don’t Expect MAHA Action
  • Interstellar Object 3I/ATLAS’s Tail Appears To Have Changed Direction
  • “It Seemingly Put On An Otherworldly Show”: Watch As This Beautiful Deep-Sea Octopus Glides Gracefully Through The Ocean
  • Have You Heard About America’s Government Cheese Caves? They’ve Got Over 600 Million Kilograms Of The Stuff Stashed Away
  • There Could Be A Surprising Health Benefit To Having Gray Hair
  • New Answer To The Fermi Paradox? Cognitive Horizon Hypothesis May Explain Why Aliens Haven’t Contacted Us
  • What Happened When Patient B-19 Was Given A Brain Stimulation Device And A Button?
  • The Ice Age Squirrel That Enabled A Plant’s Resurrection 31,800 Years Later
  • The First Video Game Came Long Before Pong And Was Invented By A Manhattan Project Physicist
  • Monster Hoaxes In The Age Of AI: Seeing Isn’t Believing Anymore
  • Business
  • Health
  • News
  • Science
  • Technology
  • +1 718 874 1545
  • +91 78878 22626
  • [email protected]
Office Address
Prudour Pvt. Ltd. 420 Lexington Avenue Suite 300 New York City, NY 10170.

Powered by Prudour Network

Copyrights © 2025 · Medical Market Report. All Rights Reserved.

Go to mobile version